Hedman A - Search Results

1

Comparison of pharmacokinetics and dynamics of two dosage regimens of foscarnet in AIDS patients with Cytomegalovirus retinitis.

Castelli F, Tomasoni L, Zeroli C, Suter F, Trespi G, Carosi G, Hedman A. Castelli F, et al. Among authors: hedman a. Eur J Clin Pharmacol. 1997;52(5):397-401. doi: 10.1007/s002280050308. Eur J Clin Pharmacol. 1997. PMID: 9272411 Clinical Trial.

2

Digoxin-interactions in man: spironolactone reduces renal but not biliary digoxin clearance.

Hedman A, Angelin B, Arvidsson A, Dahlqvist R. Hedman A, et al. Eur J Clin Pharmacol. 1992;42(5):481-5. doi: 10.1007/BF00314854. Eur J Clin Pharmacol. 1992. PMID: 1606994 Clinical Trial.

3

Effect of renal disease and hemodialysis on foscarnet pharmacokinetics and dosing recommendations.

Aweeka FT, Jacobson MA, Martin-Munley S, Hedman A, Schoenfeld P, Omachi R, Tsunoda S, Gambertoglio JG. Aweeka FT, et al. Among authors: hedman a. J Acquir Immune Defic Syndr Hum Retrovirol. 1999 Apr 1;20(4):350-7. doi: 10.1097/00042560-199904010-00005. J Acquir Immune Defic Syndr Hum Retrovirol. 1999. PMID: 10096579

4

No effect of probenecid on the renal and biliary clearances of digoxin in man.

Hedman A, Angelin B, Arvidsson A, Dahlqvist R. Hedman A, et al. Br J Clin Pharmacol. 1991 Jul;32(1):63-7. doi: 10.1111/j.1365-2125.1991.tb05614.x. Br J Clin Pharmacol. 1991. PMID: 1888643 Free PMC article.

5

Digoxin-verapamil interaction: reduction of biliary but not renal digoxin clearance in humans.

Hedman A, Angelin B, Arvidsson A, Beck O, Dahlqvist R, Nilsson B, Olsson M, Schenck-Gustafsson K. Hedman A, et al. Clin Pharmacol Ther. 1991 Mar;49(3):256-62. doi: 10.1038/clpt.1991.26. Clin Pharmacol Ther. 1991. PMID: 2007320 Clinical Trial.

6

Dose proportional absorption of 25-150 mg atenolol.

Wakelkamp M, Alván G, Paintaud G, Hedman A. Wakelkamp M, et al. Among authors: hedman a. Eur J Clin Pharmacol. 1993;44(3):305-6. doi: 10.1007/BF00271380. Eur J Clin Pharmacol. 1993. PMID: 8491252 Clinical Trial.

7

Interactions in the renal and biliary elimination of digoxin: stereoselective difference between quinine and quinidine.

Hedman A, Angelin B, Arvidsson A, Dahlqvist R, Nilsson B. Hedman A, et al. Clin Pharmacol Ther. 1990 Jan;47(1):20-6. doi: 10.1038/clpt.1990.3. Clin Pharmacol Ther. 1990. PMID: 2295215

8

Increased renal clearance of cefsulodin due to higher glomerular filtration rate in cystic fibrosis.

Hedman A, Alván G, Strandvik B, Arvidsson A. Hedman A, et al. Clin Pharmacokinet. 1990 Feb;18(2):168-75. doi: 10.2165/00003088-199018020-00006. Clin Pharmacokinet. 1990. PMID: 2180614

9

Plasma and renal clearance of iohexol--a study on the reproducibility of a method for the glomerular filtration rate.

Arvidsson A, Hedman A. Arvidsson A, et al. Among authors: hedman a. Scand J Clin Lab Invest. 1990 Nov;50(7):757-61. doi: 10.3109/00365519009091069. Scand J Clin Lab Invest. 1990. PMID: 2293336

10

Influence of the glomerular filtration rate on renal clearance of ceftazidime in cystic fibrosis.

Hedman A, Adan-Abdi Y, Alvan G, Strandvik B, Arvidsson A. Hedman A, et al. Clin Pharmacokinet. 1988 Jul;15(1):57-65. doi: 10.2165/00003088-198815010-00005. Clin Pharmacokinet. 1988. PMID: 3042246

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

292 results

Search Page

Filters